Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed; the government funding operating-status notice (and the v3.4.1 revision note) has been removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA new site-wide notice about potential delays due to a lapse in government funding has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThese are minor UI/metadata updates that do not modify core study content. They include showing the glossary option, updated capitalization for 'Last Update Submitted that Met QC Criteria', the replacement of 'No FEAR Act data' with 'No FEAR Act Data', and the revision number updated to v3.4.0.SummaryDifference0.1%

- Check64 days agoChange DetectedIntroduced a consolidated Locations section listing all study sites by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Michigan, Minnesota, New Jersey, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). The previous per-state location entries were removed.SummaryDifference1%

- Check85 days agoChange DetectedRevision label updated to v3.3.2, replacing the previous v3.3.1. This change does not alter study data or any user-facing content.SummaryDifference0.0%

- Check92 days agoChange DetectedThe Publications section now states that publications may be provided voluntarily and may be auto-filled from PubMed, and the revision tag was updated to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.